Extension Study of Ataluren (PTC124) in Cystic Fibrosis
Is a
Allocation Type
Non-Randomized
0
Trial Collaborator
Participating Facility
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Intervention Name
Ataluren
0
Interventional Trial Phase
Phase 3
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
October 19, 2020
0
Masking Type
None (Open Label)
0
Primary Completion Date
December 2, 2013
0
Trial Recruitment Size
191
0
Trial Sponsor
Clinical Trial Start Date
August 12, 2010
0
Study Completion Date
December 2, 2013
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 3 Extension Study of Ataluren (PTC124®) in Subjects With Nonsense-Mutation-Mediated Cystic Fibrosis
0
Official Website
Find more entities like Extension Study of Ataluren (PTC124) in Cystic Fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.